tm logo
ELUCIDA ONCOLOGY
Live/Registered
REGISTERED

on 27 Oct 2020

Last Applicant/ Owned by

1 Deer Park Drive, Suite E

Monmouth Junction

NJ

08852

Serial Number

87084658 filed on 27th Jun 2016

Registration Number

6185407 registered on 27th Oct 2020

in the Principal Register

Correspondent Address

Alexandra Spurr

SAUSSER SUMMERS, PC

4846 Payton Street

Santa Barbara, CA 93111

Filing Basis

1. intent to use

2. use application currently

Disclaimer

"ONCOLOGY"

ELUCIDA ONCOLOGY

The mark consists of the word "ELUCIDA" with an arrow underneath extending in to the letter "O" of the word "ONCOLOGY". Pharmaceutical preparations for the treatment of oncological disorders and diseases Color is not claimed as a feature of the mark. The English translation of "ELUCIDA" in the mark is "ELUCIDATE". "ONCOLOGY"

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of oncological disorders and diseases


First Use Date in General

30th Nov 2017

First Use Date in Commerce

30th Nov 2018

Mark Details


Serial Number

No 87084658

Mark Type

No Service/Collective Mark

Attorney Docket Number

No ELU-525-1

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

24.15.04 -

Arrowheads

26.17.01 -

Straight line(s), band(s) or bar(s)

26.17.05 -

Horizontal line(s), band(s) or bar(s)

Description of Design Search

The mark consists of the word "ELUCIDA" with an arrow underneath extending in to the letter "O" of the word "ONCOLOGY".

Legal History


Show more

Status DateAction Taken
27th Oct 2020REGISTERED-PRINCIPAL REGISTER
23rd Sep 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
22nd Sep 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11th Sep 2020STATEMENT OF USE PROCESSING COMPLETE
11th Sep 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
26th Aug 2020USE AMENDMENT FILED
26th Aug 2020TEAS STATEMENT OF USE RECEIVED
13th Feb 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11th Feb 2020EXTENSION 4 GRANTED
11th Feb 2020EXTENSION 4 FILED